Biohaven's depression drug fails mid-stage trial, shares fall

Biohaven said on Wednesday its experimental depression drug did not meet the main goal of a mid-stage trial, adding to a string of trial and regulatory setbacks for the drugmaker this year.
Morning Overview on MSNOpinion

A 500-km quake is reshaping how scientists measure risk

The 500 kilometer rupture that tore through Myanmar earlier this year did more than jolt a region already accustomed to ...
IEEE

Gaussian-Student’s t Mixture-Based Robust Probability Hypothesis Density Filter under Heavy-Tailed Process and Measurement Noises

Abstract: In multi-target tracking (MTT), the presence of heavy-tailed noise can significantly degrade tracking accuracy, which is critical in Integrated Sensing and Communication (ISAC) systems. To ...